These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38568044)

  • 21. Two distinct clinical features and cognitive impairment in amyotrophic lateral sclerosis patients with TARDBP gene mutations in the Chinese population.
    Ju X; Liu W; Li X; Liu N; Zhang N; Liu T; Deng M
    Neurobiol Aging; 2016 Feb; 38():216.e1-216.e6. PubMed ID: 26639158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the revised classification of cognitive and behavioural impairment in ALS.
    Iazzolino B; Pain D; Peotta L; Calvo A; Moglia C; Canosa A; Manera U; Ilardi A; Bombaci A; Zucchetti JP; Mora G; Chio A
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):734-739. PubMed ID: 30733331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study.
    Pilotto A; Rossi F; Rinaldi F; Compostella S; Cosseddu M; Borroni B; Filosto M; Padovani A
    Neurodegener Dis; 2016; 16(5-6):411-6. PubMed ID: 27497596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortical microstructure in the amyotrophic lateral sclerosis-frontotemporal dementia continuum.
    Illán-Gala I; Montal V; Pegueroles J; Vilaplana E; Alcolea D; Dols-Icardo O; de Luna N; Turón-Sans J; Cortés-Vicente E; Martinez-Roman L; Sánchez-Saudinós MB; Subirana A; Videla L; Sala I; Barroeta I; Valldeneu S; Blesa R; Clarimón J; Lleó A; Fortea J; Rojas-García R
    Neurology; 2020 Nov; 95(18):e2565-e2576. PubMed ID: 32913016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of the SOD1 and C9ORF72 genes in Hungarian patients with amyotrophic lateral sclerosis.
    Tripolszki K; Csányi B; Nagy D; Ratti A; Tiloca C; Silani V; Kereszty É; Török N; Vécsei L; Engelhardt JI; Klivényi P; Nagy N; Széll M
    Neurobiol Aging; 2017 May; 53():195.e1-195.e5. PubMed ID: 28222900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes.
    Millecamps S; Boillée S; Le Ber I; Seilhean D; Teyssou E; Giraudeau M; Moigneu C; Vandenberghe N; Danel-Brunaud V; Corcia P; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Cazeneuve C; Leguern E; Meininger V; Salachas F
    J Med Genet; 2012 Apr; 49(4):258-63. PubMed ID: 22499346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Molecular Landscape of ALS Patients with
    Bernard E; Pegat A; Svahn J; Bouhour F; Leblanc P; Millecamps S; Thobois S; Guissart C; Lumbroso S; Mouzat K
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants.
    Brown CA; Lally C; Kupelian V; Flanders WD
    Neuroepidemiology; 2021; 55(5):342-353. PubMed ID: 34247168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variability in sporadic amyotrophic lateral sclerosis.
    Van Daele SH; Moisse M; van Vugt JJFA; Zwamborn RAJ; van der Spek R; van Rheenen W; Van Eijk K; Kenna K; Corcia P; Vourc'h P; Couratier P; Hardiman O; McLaughin R; Gotkine M; Drory V; Ticozzi N; Silani V; Ratti A; de Carvalho M; Mora Pardina JS; Povedano M; Andersen PM; Weber M; Başak NA; Shaw C; Shaw PJ; Morrison KE; Landers JE; Glass JD; van Es MA; van den Berg LH; Al-Chalabi A; Veldink J; Van Damme P
    Brain; 2023 Sep; 146(9):3760-3769. PubMed ID: 37043475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of "insight" into behavioral changes in ALS: Differences across cognitive profiles.
    Temp AGM; Kasper E; Vielhaber S; Machts J; Hermann A; Teipel S; Prudlo J
    Brain Behav; 2022 Jan; 12(1):e2439. PubMed ID: 34855301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does wild-type Cu/Zn-superoxide dismutase have pathogenic roles in amyotrophic lateral sclerosis?
    Furukawa Y; Tokuda E
    Transl Neurodegener; 2020 Aug; 9(1):33. PubMed ID: 32811540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical markers of cognitive syndromes in amyotrophic lateral sclerosis.
    Consonni M; Contarino VE; Catricalà E; Dalla Bella E; Pensato V; Gellera C; Lauria G; Cappa SF
    Neuroimage Clin; 2018; 19():675-682. PubMed ID: 30023173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
    Hayashi Y; Homma K; Ichijo H
    Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants.
    Bertolin C; D'Ascenzo C; Querin G; Gaiani A; Boaretto F; Salvoro C; Vazza G; Angelini C; Cagnin A; Pegoraro E; Sorarù G; Mostacciuolo ML
    Neurobiol Aging; 2014 May; 35(5):1212.e7-1212.e10. PubMed ID: 24325798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
    Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
    Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: Frequency of abnormality and effect on survival.
    Xu Z; Alruwaili ARS; Henderson RD; McCombe PA
    J Neurol Sci; 2017 May; 376():16-23. PubMed ID: 28431606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS.
    Liu WC; Liu N; Wang Y; Huang C; Li YF; Wang H; Li XG; Deng M
    Chin Med J (Engl); 2021 Oct; 134(20):2457-2464. PubMed ID: 34669638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation analysis of SOD1, C9orf72, TARDBP and FUS genes in ethnically-diverse Malaysian patients with amyotrophic lateral sclerosis (ALS).
    Edgar S; Ellis M; Abdul-Aziz NA; Goh KJ; Shahrizaila N; Kennerson ML; Ahmad-Annuar A
    Neurobiol Aging; 2021 Dec; 108():200-206. PubMed ID: 34404558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond the motor account of amyotrophic lateral sclerosis: Verbal humour and its relationship with the cognitive and pragmatic profile.
    Bambini V; Bischetti L; Bonomi CG; Arcara G; Lecce S; Ceroni M
    Int J Lang Commun Disord; 2020 Sep; 55(5):751-764. PubMed ID: 32725835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive and behavioural impairment in amyotrophic lateral sclerosis: A landmark of the disease? A mini review of longitudinal studies.
    Consonni M; Dalla Bella E; Bersano E; Lauria G
    Neurosci Lett; 2021 May; 754():135898. PubMed ID: 33862143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.